Autoimmunity and clinical pathology amelioration in SLE by dexamethasone primed mesenchymal stem cell derived conditioned media
DW shows promise as a cell-free biological therapy for SLE and related autoimmune disorders, capable of modulating immune responses effectively without the adverse effects of glucocorticoids.
Authors
- Manaswi Chaubey
- Sujata Mohanty (ORCID: https://orcid.org/0000-0002-0047-4914)
- Doli Das (ORCID: https://orcid.org/0000-0002-1206-1164)
- Kiran Giri (ORCID: https://orcid.org/0000-0001-7866-6388)
- Hiral Thacker
- Geeta Rai (ORCID: https://orcid.org/0000-0001-8162-8964)
- Sonali Rawat (ORCID: https://orcid.org/0000-0001-6518-3547)
- Khushbu Priya
- Shambhavi Singh (ORCID: https://orcid.org/0000-0002-6961-2289)
- Madhukar Rai
Institutions
- Institute for Stem Cell Biology and Regenerative Medicine (IN)
- D.Y. Patil University (IN)
- Institute of Medical Sciences (IN)
- All India Institute of Medical Sciences (IN)
- Banaras Hindu University (IN)
Publication Details
- Journal
- Stem Cell Research & Therapy
- Published
- 2025-03-29
- DOI
- https://doi.org/10.1186/s13287-025-04208-6
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Science and Engineering Research Board